News on a recent patent dispute concerning a very popular prescription drug and a concerted patent strategy
In a recent patent dispute concerning a very popular prescription drug and a concerted patent strategy by the current market leader, a ruling of the High Court has enabled a new market entrant to join the market.
Our Intellectual Property blog, SnIPpets, has just posted a blog (here) about the recent High Court decision in Fujifilm Kyowa Kirin Biologics Co Ltd & Ors v AbbVie Biotechnology Ltd [2017] EWHC 395 (Pat). The blog focuses on AbbVie Biotechnolgy's conduct in relation to its dosage patent applications.